At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
VBLT Vascular Biogenics
Closed 10-16 16:00:00 EDT
5.46
+0.00
0.00%
High5.46
Low5.46
Vol0.00
Open5.46
D1 Closing5.46
Amplitude0.00%
Mkt Cap12.11M
Tradable Cap9.00M
Total Shares2.22M
T/O968.74K
T/O Rate0.00%
Tradable Shares1.65M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Notable Labs Shares Surged Over 80% after Closing Merger Transaction With VBL Therapeutics
Vascular Biogenics Ltd., a biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. It develops VB-601 using monocyte targeting technology for various inflammatory indications. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.